81 related articles for article (PubMed ID: 6189143)
1. [Whole body radiometric study of 59Fe absorption during chemotherapy of breast cancer].
Bolovin LM; Kaplan MA; Verchovskaja NI; Medvedev VN; Javor T; Bero T
Radiobiol Radiother (Berl); 1982 Nov; 23(6):705-10. PubMed ID: 6189143
[No Abstract] [Full Text] [Related]
2. [Chemotherapy of bladder cancer].
Korol'chuk VP; Shipilov VI; Romanov VA; Matveev BP
Urol Nefrol (Mosk); 1981; (3):68-72. PubMed ID: 6168085
[No Abstract] [Full Text] [Related]
3. Quality of life in women with breast cancer during the first year after random assignment to adjuvant treatment with marrow-supported high-dose chemotherapy with cyclophosphamide, thiotepa, and carboplatin or tailored therapy with Fluorouracil, epirubicin, and cyclophosphamide: Scandinavian Breast Group Study 9401.
Brandberg Y; Michelson H; Nilsson B; Bolund C; Erikstein B; Hietanen P; Kaasa S; Nilsson J; Wiklund T; Wilking N; Bergh J;
J Clin Oncol; 2003 Oct; 21(19):3659-64. PubMed ID: 14512398
[TBL] [Abstract][Full Text] [Related]
4. [High-dose chemotherapy for metastatic breast cancer without certain advantages so far].
Kleeberg UR
Strahlenther Onkol; 2000 Jul; 176(7):334-5. PubMed ID: 10963001
[No Abstract] [Full Text] [Related]
5. [Treatment of advanced breast cancer with cyclophosphamide, methotrexate, 5-fluorouracil and prednisone (CMFP)].
Rabinovich MG; Leone BA; Landó O
Medicina (B Aires); 1981; 41(1):65-70. PubMed ID: 7266359
[No Abstract] [Full Text] [Related]
6. Acute and late toxicity following adjuvant high-dose chemotherapy for high-risk primary operable breast cancer--a quality assessment study.
Svane IM; Homburg KM; Kamby C; Nielsen DL; Roer O; Sliffsgaard D; Johnsen HE; Hansen SW
Acta Oncol; 2002; 41(7-8):675-83. PubMed ID: 14651213
[TBL] [Abstract][Full Text] [Related]
7. [Adjuvant endocrine therapy and chemotherapy of breast cancer (author's transl)].
Heuson JC; Paridaens R
Rev Med Brux; 1982 Apr; 3(4):209-16. PubMed ID: 7046007
[No Abstract] [Full Text] [Related]
8. [Immediate results of the preoperative chemotherapy of breast cancer].
Gol'dman VG
Vopr Onkol; 1975; 21(10):19-22. PubMed ID: 810967
[No Abstract] [Full Text] [Related]
9. Pegase 03: a prospective randomized phase III trial of FEC with or without high-dose thiotepa, cyclophosphamide and autologous stem cell transplantation in first-line treatment of metastatic breast cancer.
Biron P; Durand M; Roché H; Delozier T; Battista C; Fargeot P; Spaeth D; Bachelot T; Poiget E; Monnot F; Tanguy ML; Curé H
Bone Marrow Transplant; 2008 Mar; 41(6):555-62. PubMed ID: 18037940
[TBL] [Abstract][Full Text] [Related]
10. Combination chemotherapy in advanced breast cancer. A report of the Working Party of the Multicentre Cancer Chemotherapy Group.
Spittle MF; Bates TD; Kitchen G; Nicol NT; Wheeler T; Edelstyn G; MacRae KD; Ostrowski MJ
Clin Oncol; 1980 Jun; 6(2):153-7. PubMed ID: 7408282
[No Abstract] [Full Text] [Related]
11. [Treatment of advanced breast cancer with 2 successive chemotherapeutic schedules].
Pérez JE; Machiavelli M; Romero A; Leone BA; Rabinovich MG; Arévalo E
Medicina (B Aires); 1982; 42(6 Pt 1):587-95. PubMed ID: 6897849
[No Abstract] [Full Text] [Related]
12. [Results of "5-drug" treatment of advanced breast cancer].
Dorociak R
Pol Tyg Lek; 1981 Sep; 36(38):1467-70. PubMed ID: 7329862
[No Abstract] [Full Text] [Related]
13. The additive effect of peripheral blood stem cells, harvested with low-dose cyclophosphamide, to autologous bone marrow reinfusion on hematopoietic reconstitution after ablative chemotherapy in breast cancer patients with localized disease.
de Graaf H; Mulder NH; Willemse PH; van der Graaf WT; Sleijfer DT; Zijlstra JG; Elias M; Sibinga CT; Vellenga E; de Vries EG
Anticancer Res; 1995; 15(6B):2851-6. PubMed ID: 8669878
[TBL] [Abstract][Full Text] [Related]
14. [On intra-arterial chemotherapy of stomach cancer].
Chernyĭ VA
Vopr Onkol; 1969; 15(7):93-4. PubMed ID: 4980427
[No Abstract] [Full Text] [Related]
15. [Effect of antiblastic polychemotherapy (CMF) on the number of circulating monocytes in patients with breast cancer].
Bariani L; Dolcetti U; Indelli M; Gualandi G; Malacarne P; Castaldi G
Minerva Med; 1982 Oct; 73(39):2641-8. PubMed ID: 7121879
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of various breast cancers with continuous and protracted intra-arterial perfusion of antimiotics].
Magendie JJ; Périssat J
Mem Acad Chir (Paris); 1967 Apr; 93(13):403-10. PubMed ID: 4980451
[No Abstract] [Full Text] [Related]
17. [Medical treatment of early breast cancer: chemotherapy].
Ejlertsen B; Kamby C
Ugeskr Laeger; 2007 Sep; 169(37):3070-2. PubMed ID: 17877950
[TBL] [Abstract][Full Text] [Related]
18. [Combination chemotherapy in metastatic breast cancer].
Kuten A; Lev L; Mohaliver J; Robinson E
Harefuah; 1981 Feb; 100(3):118-20. PubMed ID: 7262675
[TBL] [Abstract][Full Text] [Related]
19. Influence of smoking history on breast cancer prognosis: retrospective study of 240 operable breast cancer patients who received adjuvant cyclophosphamide, doxorubicin, and 5-fluorouracil chemotherapy regimen.
Aksoy S; Harputluoglu H; Guler N; Altundag K; Hayran M; Tekuzman G; Ozisik Y
Breast J; 2007; 13(4):431-2. PubMed ID: 17593056
[No Abstract] [Full Text] [Related]
20. [Multicentric prospective, randomized study of the role of filgrastim (G-CSF) after transplant of hematopoietic progenitor cells mobilized with G-CSF in patients with cancer of the breast].
Hornedo J; Sola C; Solano C; Lluch A; Benavides M; López López J; García Conde J; Cortés-Funes H
Sangre (Barc); 1997 Apr; 42 Suppl 1():54-6. PubMed ID: 9381305
[No Abstract] [Full Text] [Related]
[Next] [New Search]
